Daxor logo thumbnail.png
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
19 sept. 2024 08h00 HE | Daxor Corporation
Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual...
Daxor logo thumbnail.png
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
12 sept. 2024 08h00 HE | Daxor Corporation
Review Published in the Prestigious Journal Cardiorenal Medicine Oak Ridge, TN, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...
Daxor logo thumbnail.png
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
05 sept. 2024 08h00 HE | Daxor Corporation
The SBIR Matching Fund Award Will Drive Our Innovation, Commercialization Efforts, and Job Creation Oak Ridge, TN, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global...
Daxor logo thumbnail.png
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
04 sept. 2024 08h30 HE | Daxor Corporation
1,000 Bed Comprehensive Medical Center Launches ezBVA Lab Program Oak Ridge, TN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...
Daxor logo thumbnail.png
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
03 sept. 2024 16h05 HE | Daxor Corporation
Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update...
Daxor logo thumbnail.png
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
03 sept. 2024 12h15 HE | Daxor Corporation
Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh...
Daxor logo thumbnail.png
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network
29 août 2024 08h00 HE | Daxor Corporation
Community Hospital Purchases BVA Analyzer With Focus on Improving Outpatient Heart Failure Care Oak Ridge, TN, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader...
Daxor logo thumbnail.png
Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer
06 août 2024 08h00 HE | Daxor Corporation
Oak Ridge, TN, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it has been awarded a $1.9M two-year...
Daxor logo thumbnail.png
Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide
05 août 2024 08h00 HE | Daxor Corporation
Daxor's ezBVA Lab Service Spearheads Growth and Broader Market Adoption Oak Ridge, TN, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...
Daxor logo thumbnail.png
Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer
24 juil. 2024 08h00 HE | Daxor Corporation
The Hematocrit Feature Will Be Integrated Into A Future Generation Blood Volume Analyzer (BVA) Oak Ridge, TN, July 24, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader...